An interventional study of Abdominal Functional Electrical Stimulation in Spinal Cord Injuries and Neurogenic Bowel, sponsored by Craig Hospital. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-31.
Sponsored by Craig Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 21 studies in Spinal Cord Injuries by Craig Hospital — 6 open to participants now, 7 under way, none of them phase 3. Spinal Cord Injuries · Craig Hospital.
Among the 21 studies in Spinal Cord Injuries by Craig Hospital, this one is the 15th largest by planned enrollment of the 17 interventional ones that give a count, is one of 4 that started in 2025, is one of 14 with no phase, and was the 17th registered.
2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.
Browse Spinal Cord Injuries studies →6 of the 21 studies in Spinal Cord Injuries by Craig Hospital are open now, in 1 country. Recruiting first, the newest first:
Craig Hospital · Sites in United States
Ages 18+ · Healthy volunteers
Craig Hospital · Sites in United States
Ages 18–89 · Men only
Craig Hospital · Sites in United States
Ages 18+
Craig Hospital · Sites in United States
Ages 18–89 · Healthy volunteers
Craig Hospital · Sites in United States
Ages 18+
By country, each count listing its studies:
Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
21 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 2 · Phase 4 1
First in 2006; this study’s year is marked. 4 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 15 is below the median of 24 across 1,639 interventional studies indexed under Spinal Cord Injuries.
Median enrollment 37 across the 17 interventional studies, 44 across the 4 observational. Of the 11 that completed or were terminated, 1 (9%) have results posted.
This tab as a report to print or save as PDF → With an account.
Craig Hospital is the lead sponsor of 38 studies on the registry; 11 are open to participants now.
4 of the studies in Spinal Cord Injuries by Craig Hospital that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05191121Craig HospitalImproving Upper Extremity Function and Trunk Stability After Cervical Spinal Cord Injury (SCI) | 2027-02 |
| NCT06443151Craig HospitalRole of Endothelial Function in SCI CVD Risk | 2027-03-30 |
| NCT07227727Craig HospitalEndothelial Dysfunction After SCI | 2027-07-30 |
| NCT06743607Craig HospitalSpinal Stimulation for Upper Extremity Recovery in the Home | 2027-08 |
Add all 4 to your calendar (.ics) → With an account.
Among the 21 studies in Spinal Cord Injuries by Craig Hospital, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The primary objective of this study is to gather information about the effectiveness of abdominal FES to improve bowel management time (BMT) for people with chronic SCI. This study will also evaluate whether abdominal FES can improve: 1) bowel-related quality of life, 2) participant-reported bowel function, 3) bowel management strategy, 4) bladder symptoms, and 5) unplanned hospital admissions. In addition, we will also explore participant perspectives and experiences about the stimulation sessions and use of the device.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
a measurable and consistent start and end event is determinable for the bowel routine
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
All participants enrolled will receive the intervention.
Behavioral: Abdominal Functional Electrical Stimulation
Functional electrical stimulation electrodes will be applied to the abdomen during a bowel program to assess effects of stimulation on bowel management time.
Bowel Management Time (BMT)
This is measured by recording start and end time of bowel management session in study diary.
Time frame: Daily (Weeks 1-10)
Bowel Management Strategy
This will be measured via analysis of daily diary entries regarding bowel movements (time taken and frequency), dietary changes or inconsistencies, and use of laxatives and manual procedures. The bowel diary will be completed daily throughout the study by participants and/or their caregivers.
Time frame: Daily (Weeks 1-10)
Stimulation Dose
This will be recorded by the participant. Participants will be asked to record the total time of active stimulation as displayed by the stimulation counter/timer and the intensity of the stimulation (milliamps) for each BM session in their bowel diary. The stimulation device will also record number of times the device button is depressed and duration in seconds, which can be downloaded at a later date by the research team providing further detail on stimulation dose.
Time frame: During active stimulation period (Weeks 3-7)
EuroQoL 5 Dimension 5 Level (EQ-5D-5L) Questionnaire
Quality of Life measure
Time frame: Week 1, Week 3, Week 7, Week 10
International Spinal Cord Society's (ISCoS) International SCI Bowel Function Basic Data Set Questionnaire
This instrument measures participant-reported bowel function bowel function.
Time frame: Week 1, Week 3, Week 7, Week 10
Visual Analog Scale (VAS)
This instrument measures participant perceptions of bowel function satisfaction on a rating scale from 0-100.
Time frame: Week 1, Week 3, Week 7, Week 10
Neurogenic Bladder Symptom Score (NBSS)
This instrument measures neurogenic bladder symptoms
Time frame: Week 1, Week 3, Week 7, Week 10
Intervention Acceptability
Qualitative and quantitative analysis of abdominal functional stimulation (AFES) use will be measured at the end of the active trial period, using both open-ended and 10-scored theoretical framework of acceptability questions to gain the perspective of people with lived experience of SCI on the use of AFES during a bowel routine
Time frame: Week 7
Intervention Safety
This will be determined by the reporting and summarization of any adverse events associated with the interventions. Participants will be instructed to record any adverse events in their bowel diaries and to call study staff immediately to review. Unplanned hospital visits will also be recorded in the study diary.
Time frame: Daily (Weeks 0-10)
Started Apr 2025 (actual). Primary completion is estimated for May 2026, 13 months after the start.
Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 13 months is below that.
Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Craig Hospital